Eventide Asset Management - CATALYST BIOSCIENCES INC ownership

CATALYST BIOSCIENCES INC's ticker is CBIO and the CUSIP is 14888D208. A total of 43 filers reported holding CATALYST BIOSCIENCES INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Eventide Asset Management ownership history of CATALYST BIOSCIENCES INC
ValueSharesWeighting
Q3 2019$2,273,000
-33.4%
462,8520.0%0.08%
-27.9%
Q2 2019$3,411,000
-9.1%
462,8520.0%0.10%
-19.4%
Q1 2019$3,754,000
+93.4%
462,852
+88.2%
0.13%
+50.0%
Q4 2018$1,941,000
-26.8%
246,0000.0%0.09%
-11.3%
Q3 2018$2,652,000
-7.6%
246,0000.0%0.10%
-18.5%
Q2 2018$2,871,000246,0000.12%
Other shareholders
CATALYST BIOSCIENCES INC shareholders Q3 2019
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 834,449$5,265,0004.03%
ACUTA CAPITAL PARTNERS, LLC 1,357,500$8,566,0002.33%
22NW, LP 772,314$4,873,0001.74%
AIGH Capital Management LLC 421,042$2,657,0001.08%
Altium Capital Management LP 313,745$1,980,0000.74%
Worth Venture Partners, LLC 99,297$627,0000.50%
Nantahala Capital Management 1,865,334$11,770,0000.36%
Parkman Healthcare Partners LLC 189,161$1,194,0000.31%
Sio Capital Management, LLC 188,714$1,191,0000.24%
Essex Woodlands Management, Inc. 78,622$496,0000.13%
View complete list of CATALYST BIOSCIENCES INC shareholders